The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

By S. Swerdlow, E. Campo, S. Pileri, N. Harris, H. Stein, R. Siebert, R. Advani, M. Ghielmini, G. Salles, A. Zelenetz and 1 more. Blood, 2016

2,257 citations recorded by the source corpus.

Subfields: Dermatology, Genetics, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/996ef61ea9d23b08b3adbd4651b04a968b0b8827

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. X. Mariette
2. P. Brito-Zerón
3. M. Ramos-Casals
4. Jacques-Eric Gottenberg
5. H. Bootsma
6. T. Dörner
7. R. Seror
8. S. Bombardieri

Citations in the corpus

• EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies (2019, positive): “…the diagnosis of lymphoma, therapy should be individualised according to the specific histological subtype defined according to the WHO 2016 classification 89 and the corresponding current therapeutic guidelines, with a personalised therapeutic approach driven by the haematologist/oncologist.”